Nicotinomide
CTU/2020/365
Phase 3 small_molecule active
Quick answer
Nicotinomide for Glaucoma, Open-Angle is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Glaucoma, Open-Angle
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active